Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rani Khatib

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Postgraduate Medical Journal|October 30, 2020
Managing drug-induced QT prolongation in clinical practiceRani Khatib, Fatima R N Sabir, Caroline Omari, et al.
Open Heart|April 8, 2022
Innovative, centralised, multidisciplinary medicines optimisation clinic for PCSK9 inhibitorsRani Khatib, Mutiba Khan, Abigail Barrowcliff, et al.
BMJ Open Quality|April 17, 2023
Developing a post-myocardial infarction medicines optimisation clinic: core competencies for upskilling pharmacists and initial patient feedbackRuth Price, Franki Wilson, Alistair Hall, et al.
Open Heart|January 8, 2019
Re-engineering the post-myocardial infarction medicines optimisation pathway: a retrospective analysis of a joint consultant pharmacist and cardiologist clinic modelRani Khatib, Nasrin Patel, Una Laverty, et al.
European Journal of Hospital Pharmacy : Science and Practice|June 4, 2019
Optimal dosing of angiotensin-converting enzyme inhibitors and β-blockers for acute coronary syndrome: up-titration remains a challengeNatasha Sharma, Rani Khatib, Nadir Elamin, et al.
Frontiers in Cardiovascular Medicine|September 24, 2024
Supporting appropriate use of extended dual antiplatelet therapy post-myocardial infarction based on an innovative 12-month ticagrelor virtual serviceRani Khatib, Abigail Barrowcliff, Franki Wilson, et al.
European Journal of Cardiovascular Nursing|December 1, 2021
Perceptions of injectable therapies with cardiovascular benefit: an ACNAP survey of healthcare professionals to explore facilitators and barriersRani Khatib, Neil Angus, Tina B Hansen, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 15, 2026
Cardiovascular Risk Estimation and Statin Adherence: A Historical Cohort StudySamuel Finnikin, Brian Willis, Tim Evans, et al.
European Journal of Cardiovascular Nursing|May 24, 2024
Healthcare professionals' perspectives on the use of PCSK9 inhibitors in cardiovascular disease: an in-depth qualitative studyGeraldine A Lee, Angela Durante, Edward E Baker, et al.
Journal of Advanced Nursing|June 28, 2023
Patients' perceptions on the facilitators and barriers using injectable therapies in dyslipidaemia: An empirical qualitative descriptive international studyGeraldine A Lee, Angela Durante, Edward E Baker, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Postgraduate Medical Journal|October 30, 2020
Managing drug-induced QT prolongation in clinical practiceRani Khatib, Fatima R N Sabir, Caroline Omari, et al.
Open Heart|April 8, 2022
Innovative, centralised, multidisciplinary medicines optimisation clinic for PCSK9 inhibitorsRani Khatib, Mutiba Khan, Abigail Barrowcliff, et al.
BMJ Open Quality|April 17, 2023
Developing a post-myocardial infarction medicines optimisation clinic: core competencies for upskilling pharmacists and initial patient feedbackRuth Price, Franki Wilson, Alistair Hall, et al.
Open Heart|January 8, 2019
Re-engineering the post-myocardial infarction medicines optimisation pathway: a retrospective analysis of a joint consultant pharmacist and cardiologist clinic modelRani Khatib, Nasrin Patel, Una Laverty, et al.
European Journal of Hospital Pharmacy : Science and Practice|June 4, 2019
Optimal dosing of angiotensin-converting enzyme inhibitors and β-blockers for acute coronary syndrome: up-titration remains a challengeNatasha Sharma, Rani Khatib, Nadir Elamin, et al.
Frontiers in Cardiovascular Medicine|September 24, 2024
Supporting appropriate use of extended dual antiplatelet therapy post-myocardial infarction based on an innovative 12-month ticagrelor virtual serviceRani Khatib, Abigail Barrowcliff, Franki Wilson, et al.
European Journal of Cardiovascular Nursing|December 1, 2021
Perceptions of injectable therapies with cardiovascular benefit: an ACNAP survey of healthcare professionals to explore facilitators and barriersRani Khatib, Neil Angus, Tina B Hansen, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 15, 2026
Cardiovascular Risk Estimation and Statin Adherence: A Historical Cohort StudySamuel Finnikin, Brian Willis, Tim Evans, et al.
European Journal of Cardiovascular Nursing|May 24, 2024
Healthcare professionals' perspectives on the use of PCSK9 inhibitors in cardiovascular disease: an in-depth qualitative studyGeraldine A Lee, Angela Durante, Edward E Baker, et al.
Journal of Advanced Nursing|June 28, 2023
Patients' perceptions on the facilitators and barriers using injectable therapies in dyslipidaemia: An empirical qualitative descriptive international studyGeraldine A Lee, Angela Durante, Edward E Baker, et al.
Pageof 4